Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services
FDA, U.S. Food and Drug Administration
U.S. Food & Drug Administration
 
  • A to Z Index
  • Follow FDA
  • FDA Voice Blog
Search
 
Most Popular Searches
 
  • Home
  • Food
  • Drugs
  • Medical Devices
  • Vaccines, Blood & Biologics
  • Animal & Veterinary
  • Cosmetics
  • Radiation-Emitting Products
  • Tobacco Products
 

Import Alert 66-35

  • Print
  • Share
  • E-mail
  • FDA Home
  • Import Program
  • Import Alerts
  • Imports Alerts by Number
  • Import Alert
-

(Note: This import alert represents the Agency's current guidance to FDA field personnel regarding the manufacturer(s) and/or products(s) at issue. It does not create or confer any rights for or on any person, and does not operate to bind FDA or the public).

Import Alert # 66-35
Published Date: 03/18/2011
Type: DWPE with Surveillance
Import Alert Name:
"Detention Without Physical Examination of Redotex and Other Diet Pills From Mexico"

Reason for Alert:
Dallas district has reported that some clinics in Nuevo Laredo, Mexico are engaged in the business of selling potentially dangerous combinations of otherwise possibly useful drug products to U.S. citizens for weight loss.

According to newspaper accounts, the diet regimen consists of several drugs including diuretics, laxatives, thyroid hormones, depressants and antihistamines. The primary drug associated with the diet regimen is called Redotex, manufactured by Medix, a Mexican pharmaceutical company. According to the Mexican Diccionario de Especialidades Farmaceuticas (Mexican equivalent to PDR) each capsule of Redotex consists of the following:

English Translation (Spanish)

o Tri iodothyronine (Triyodotironina) 75 mcg. A hormone used to increase the metabolic rate of tissues.

o Norpseudoephedrine (Clorhidrato de D Norseudoefedrina) 50 mg. An amphetamine like drug.

o Atropine sulfate (Sulfato de Atropina) 0.36 mg. Used as a respiratory and circulatory stimulant.

o Aloin (Aloina) 16.2 mg. Laxative.

o Diazepam (Diacepam) 8 mg. A depressant (Valium).

Other drugs associated or used in conjunction with Redotex include:

1) Ponderex 40 (Clorhidrato de Fenfluramina) 40 mg. Manufactured by A.H. Robbins de Mexico

2) Moduretic Manufactured by Merck Sharp and Dome de Mexico.

3) Asenlix (Clorhidrato de Clobenzorex) 30 mg. Manufactured by Grupo Russellsa Mexican Pharmaceutical Co.

4) Ionamin (Complijo de Resina de Fentermina) (equivalente a 30 mg. de fenil ter butiliamina) 142 mg., manufactured by Pennwalt Labs de Mexico.

5) Fluddro Furosemide

The products normally given to patients consist of Redotex and product number 1 and number 2 listed above. Products 3 and 4 listed above have been reported to be substituted for Redotex in some instances. Newspaper accounts have also reported the occassional use of product 5.

A health hazard evaluation by CDB of the product Redotex has revealed that the use of Redotex poses a health hazard, especially when taken without adequate medical supervision. The irrational combination of these thyroid, diurectic, stimulant and tranquilizer drugs may cause serious and potentially fatal adverse reactions. These would include alteration of metabolic rate, increased heart rate, lowering or increasing of blood pressure, loss of body electrolytes by diuretic action, as well as confusion and hallucinatory states.

Guidance:
Districts may detain without physical examination all entries, including those encountered by U.S. Customs during routine examination of personal baggage, of Redotex; and the other diet drugs mentioned above if encountered in combination with Redotex and charge: "The article(s) are violative within the meaning of 801(a) (3) in that it appears to be a new drug without an approved New Drug Application (NDA) pursuant to section 505; and it is misbranded under Section 502."

Alert your local Customs of FDA's interest in these products, however, emphasize to Customs that FDA's interest regarding examination of personal baggage is limited only to routine examination.

Product Description:
Redotex diet pills

Charge:
"The article(s) are violative within the meaning of 801(a) (3) in that it appears to be a new drug without an approved New Drug Application (NDA) pursuant to section 505; and it is misbranded under Section 502."

OASIS Charge Code - UNAPPROVED

Countries

MEXICO
(66 ! - ! --)

List of firms and their products subject to Detention without Physical Examination (DWPE) under this Import Alert (a.k.a. Red List)



MEXICO

A.H. Robbins de Mexico
Date Published : 09/10/2009

Unknown Street , Unknown, MEXICO
66 F - - 99 Suppressant N.E.C.
Date Published: 09/10/2009


Grupo Russellsa - Mexican Pharmaceutical Co.
Date Published : 09/10/2009

Unknown Street , Unknown, MEXICO
66 F - - 99 Suppressant N.E.C.
Date Published: 09/10/2009


Merck Sharp & Dohme Mexico
Date Published : 09/10/2009

Av Division Del Norte 3377 , Col Xotepingo , Coyoacan, MEXICO
66 F - - 99 Suppressant N.E.C.
Date Published: 09/10/2009


Pennwalt Labs de Mexico
Date Published : 09/10/2009

Unknown Street , Unknown, MEXICO
66 F - - 99 Suppressant N.E.C.
Date Published: 09/10/2009


Productos Medix, S.A. (Medix)
Date Published : 09/10/2009

Unknown Street , Unknown, MEXICO
66 F - - 99 Suppressant N.E.C.
Date Published: 09/10/2009


-
-

Links on this page:

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.


  • Accessibility
  • Contact FDA
  • Careers
  • FDA Basics
  • FOIA
  • No Fear Act
  • Site Map
  • Transparency
  • Website Policies
FDA
U.S. Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
Ph. 1-888-INFO-FDA (1-888-463-6332)
Email FDA
  • USA.gov
  • E-mail
  • RSS
  • Twitter
  • Facebook
  • YouTube
  • Flickr
  • For Government
  • For Press
  • Combination Products
  • Advisory Committees
  • Science & Research
  • Regulatory Information
  • Safety
  • Emergency Preparedness
  • International Programs
  • News & Events
  • Training and Continuing Education
  • Inspections/Compliance
  • State & Local Officials
  • Consumers
  • Industry
  • Health Professionals
U.S. Department of Health & Human Services
 

Links on this page: